INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 152 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $377,546 | +111270.5% | 33,800 | +34.2% | 0.00% | – |
| Q1 2023 | $339 | -99.9% | 25,182 | -29.5% | 0.00% | -100.0% |
| Q3 2022 | $586,000 | +31.1% | 35,700 | +9.2% | 0.00% | – |
| Q2 2022 | $447,000 | -13.7% | 32,700 | +2.5% | 0.00% | – |
| Q1 2022 | $518,000 | -43.1% | 31,900 | -42.8% | 0.00% | -100.0% |
| Q4 2021 | $911,000 | -4.4% | 55,800 | -11.1% | 0.00% | 0.0% |
| Q3 2021 | $953,000 | +4.2% | 62,800 | +44.7% | 0.00% | -50.0% |
| Q2 2021 | $915,000 | +17.2% | 43,400 | +25.8% | 0.00% | 0.0% |
| Q1 2021 | $781,000 | -49.1% | 34,500 | -42.5% | 0.00% | 0.0% |
| Q4 2020 | $1,535,000 | -42.6% | 60,000 | -6.2% | 0.00% | -71.4% |
| Q3 2020 | $2,672,000 | -23.0% | 63,965 | -13.9% | 0.01% | -22.2% |
| Q2 2020 | $3,471,000 | -39.3% | 74,326 | -15.5% | 0.01% | -47.1% |
| Q1 2020 | $5,721,000 | -73.4% | 87,962 | -49.6% | 0.02% | -67.9% |
| Q4 2019 | $21,529,000 | +77.7% | 174,416 | -7.7% | 0.05% | +51.4% |
| Q3 2019 | $12,115,000 | -16.5% | 188,944 | +3.6% | 0.04% | -14.6% |
| Q2 2019 | $14,517,000 | -46.7% | 182,458 | -25.1% | 0.04% | -48.8% |
| Q1 2019 | $27,260,000 | +41.3% | 243,704 | +18.8% | 0.08% | +48.1% |
| Q4 2018 | $19,290,000 | -14.2% | 205,105 | +15.3% | 0.05% | +8.0% |
| Q3 2018 | $22,472,000 | +172.3% | 177,840 | +32.6% | 0.05% | +150.0% |
| Q2 2018 | $8,253,000 | 0.0% | 134,162 | 0.0% | 0.02% | 0.0% |
| Q1 2018 | $8,253,000 | -40.9% | 134,162 | +17.9% | 0.02% | -68.8% |
| Q2 2017 | $13,972,000 | +20.5% | 113,835 | +10.9% | 0.06% | 0.0% |
| Q1 2017 | $11,591,000 | -30.2% | 102,685 | -32.8% | 0.06% | -22.0% |
| Q4 2016 | $16,613,000 | -23.0% | 152,900 | +13.6% | 0.08% | -18.8% |
| Q3 2016 | $21,566,000 | +23.0% | 134,600 | +15.0% | 0.10% | +2.0% |
| Q2 2016 | $17,535,000 | – | 117,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |